|
|
| 254.79 Real-Time Quote |  -0.01 / -0.00%Today’s Change | 153.07 Today|||52-Week Range 275.40 | +12.21% Year-to-Date |
The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc. The fund is non-diversified.
| Pressing Like A Panini Soon Mar 13 / StockTwits | Sloppy Action Mar 11 / StockTwits |
| Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT) Mar 13 / Benzinga | Chunky Monday Mar 10 / StockTwits |
| Choppy, But Getting Better Mar 13 / StockTwits | Wait for the Triggers Mar 07 / TheStreet.com |
| 1 month | -1.90% | 3 years | +38.85% | |
| 3 months | +18.24% | 5 years | +31.71% | |
| 1 year | +63.48% | Since inception | +7.55% |
| Previous close | $254.80 |
| Open day’s range | 251.79 – 256.73 |
| Net asset value (NAV) | 254.92 (03/13/2014) |
| Daily volume | 945,045 |
| Average volume (3 months) | 1,308,061 |
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +31.71% | +21.91% |
| Expense Gross exp ratio | 0.48% | 0.43% |
| Risk 5 year sharpe ratio | 1.74 | 1.72 |
| Net assets | $5.8B | $1.3B |
| Average market cap | $14.6B | $28.7B |
| Average P/E | 35.4 | 26.6 |
| Dividend / Share | -- | 0.22% |
| RYH Guggenheim S&P 500® Equal Weight Health... |
| VHT Vanguard Health Care ETF |
| XLV Health Care Select Sector SPDR® Fund |
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
| BIIB Biogen Idec Inc | 7.89% |
| GILD Gilead Sciences Inc | 7.45% |
| AMGN Amgen Inc | 7.32% |
| REGN Regeneron Pharmaceuticals, Inc. | 6.82% |
| CELG Celgene Corporation | 6.69% |
| ILMN Illumina, Inc. | 4.81% |
| ALXN Alexion Pharmaceuticals, Inc. | 4.78% |
| MYL Mylan Inc | 4.24% |
| VRTX Vertex Pharmaceuticals Inc | 3.92% |
| BMRN Biomarin Pharmaceutical, Inc. | 2.55% |
.
